Annual report [Section 13 and 15(d), not S-K Item 405]

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.25.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended
Jul. 28, 2016
Dec. 31, 2024
Dec. 31, 2023
BioCorRx Pharmaceuticals [Member]      
Ownership percentage held by Company 75.80%    
Director [Member]      
Compensation and interest payable   $ 1,349,465 $ 1,683,453